Word: barretts
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...family continues to fund the scholarship, 110 years after Barrett Wendell founded it in honor of his father, Jacob...
...festival of fossil fuel. Six hundred million people around the world watched some part of the season on television. That's why companies such as Korean electronics conglomerate LG Group are prepared to lay out "several hundred million dollars" to have their logo plastered all over F1, says Andrew Barrett, the company's VP of global sponsorship, who recently inked such a deal. "We were looking for as broad a global reach as we could get with one sport, and nothing else even came close." (See the 50 worst cars of all time...
...Still, the pair deserved to score as high as the American teams. Caydee Denney and Jeremy Barrett, who came in 13th place, were solid, but I wanted to see more athleticism. They spent an inordinate chunk of their routine mindlessly waving their arms around. A few timing issues aside, Americans Mark Ladwig and Amanda Evora, who finished 10th, were truly terrific. They scored significantly higher than the French team, which didn't feel right. Perhaps the judges really do dock you for milking...
...Enter Barrett. Before being hired to head Cardinal's drug-distribution business in early 2008, Barrett ran the North American operations of Teva, one of the world's largest generic-drug manufacturers. Barrett immediately focused on luring back independent-pharmacy customers, which are more profitable and rely on wholesalers for generics. The first step was to reopen all supply channels by paying $34 million to settle the DEA's allegations surrounding the firm's role in filling fake prescriptions. Then Barrett narrowed Cardinal's sources for generics from 120 to a few dozen to ensure that it could consistently offer...
...company's revival isn't completely assured. For instance, Cardinal will have to act fast if, as Barrett says, it wants to catch up with rivals on delivering specialty drugs. Netting $134 billion globally in 2008, these therapies for treating chronic diseases--about half of which are oncology drugs--represent one of the fastest-growing segments of the health care market. AmerisourceBergen's revenue in the sector topped $16 billion last fiscal year. "If Cardinal is going to play, they have to move now," says Sanford C. Bernstein & Co. analyst Helene Wolk, who is bearish on Cardinal. "And they...